Results 1 to 10 of about 11,835,394 (361)
The gut–liver axis and gut microbiota in health and liver disease
Nature Reviews Microbiology, 2023 Bernd Schnabl
exaly +2 more sources
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Hepatology, 2023 The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language.
M. Rinella +52 more
semanticscholar +2 more sources
Canadian Journal of Gastroenterology and Hepatology, 2022 Objectives. We assessed the potential of glial cell line-derived neurotrophic factor (GDNF) as a useful biomarker to predict cirrhosis in chronic hepatitis B (CHB) patients. Methods.
Guangyue Yang +17 more
doaj +1 more source
Analytical Cellular Pathology, 2022 Nowadays, microRNA-375 (miR-375) has been implicated in many types of cancers, including hepatocellular carcinoma (HCC), and the functions of miRNAs encapsulated by extracellular vesicles (EV) in HCC progression have also been extensively investigated ...
Zhaoxia Yu +5 more
doaj +1 more source
BMC Gastroenterology, 2023 Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and is characterized by insidious onset, rapid progression, and poor prognosis. Immunotherapy is a first-line treatment for advanced HCC.
Rui Hu +13 more
doaj +1 more source
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Journal of Obesity & Metabolic Syndrome, 2023 Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome.
W. Chan +5 more
semanticscholar +1 more source
Emergency Medicine International, 2022 Objectives. To investigate the effects of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) on liver function and immune function in patients with hepatocellular carcinoma (HCC). Methods.
Yan Zhou +6 more
doaj +1 more source
Scientific Reports, 2023 Peripheral blood mononuclear cell (PBMC) genes reflect the host immune status and could be suitable for evaluating the prognosis of patients with hepatocellular carcinoma (HCC), for which a reliable biomarker is unavailable and the host immune responses ...
Jing Li +10 more
doaj +1 more source
MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.
Gastroenterology, 2020 Fatty liver associated with metabolic dysfunction is common, affects a quarter of the population, and has no approved drug therapy. While pharmacotherapies are in development, response rates appear modest.
M. Eslam, A. Sanyal, J. George
semanticscholar +1 more source
Exploring the landscape of steatotic liver disease in the general US population
Liver international (Print), 2023 The aim of the present study is to explore the epidemiologic impact of the definition of steatotic liver disease (SLD) proposed by a multi‐society (American Association for the Study of the Liver‐the European Association for the Study of Liver Diseases ...
S. Ciardullo +3 more
semanticscholar +1 more source